📋 Arbutus Biopharma Corporation (ABUS) - Other Event
Filing Date: 2026-01-16
Accepted: 2026-01-16 07:41:46
Event Type: Other Event
Event Details:
Arbutus Biopharma Corporation (ABUS) Provides Business Update
Arbutus Biopharma Corporation (ABUS) issued a business update covering recent developments.
expected in the next few months. The Company disagrees with the outcome, and upon receipt of the written decision, the Company plans to file a petition for review by the Enlarged Board of Appeal of the EPO. The decision is likely to affect the case brought by the Company and its licensee Genevant Sciences GmbH (“Genevant”) against Moderna in Switzerland and one of two cases brought by the Company and Genevant against Moderna in the Unified Patent Court (Case UPC_CFI_191/2025
🔍 Detailed Event Analysis:
AI Summary: 13e-4(c)) : Title of each class Trading Symbol(s) Name of each exchange on which registe.
📋 Arbutus Biopharma Corporation (ABUS) - Other Event
Filing Date: 2026-01-16
Accepted: 2026-01-16 07:41:46
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: 13e-4(c)) : Title of each class Trading Symbol(s) Name of each exchange on which registe.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: